title: Certification denied in pharmaceutical class action.
authors.affiliation: McMillan LLP, Toronto.
authors.forename: Adrienne
authors.initials: A
authors.lastname: Boudreau
authors.forename: Anna
authors.initials: A
authors.lastname: Tombs
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002170:Canada; D003987:Dibenzothiazepines / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D056687:Off-Label Use / Q000331:legislation & jurisprudence; D000069348:Quetiapine Fumarate
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate